Partner Article
Teesside University biochem spin-out venture moves into Redcar’s Wilton Centre
TeeGene Biotech, a spin-out venture from Teesside University, has taken up space at the Wilton Centre after taking part in the icreate entrepreneurs programme.
The firm, which carries out biochemical research, is also exploring anti-ageing product, TeeGene Biotech, targeted at the cosmetics industry.
Dr Pattanathu Rahman, founding director of TeeGene Biotech, is a Senior Lecturer in Process Engineering and Biotechnology at Teesside University with 20 years of research experience.
Dr Rahman said: “The EU has established a market for biosurfactants, with an estimated demand of 679 million Euros last year corresponding to half of the global demand.
“The predicted value for biosurfactant market is 1.8 billion Euros by 2030, which is a 300% increase,”
“We are a research-led company, looking to widen the variety of known biosurfactants and bring these to market.
“We want to develop the application area for which biosurfactants are used and branch into other industries. We also lease our platform out to enable access via a franchise model. This enables wider geographical implementation, allowing manufacture in other parts of the world, reducing the carbon footprint associated with transportation.”
This was posted in Bdaily's Members' News section by Ellen Forster .
Enjoy the read? Get Bdaily delivered.
Sign up to receive our daily bulletin, sent to your inbox, for free.
Are you a meat proxy?
Engaging the five-generation workplace
Talent is an asset, not an operational resource
Taking advantage of the opportunities ahead
Accountability isn’t the enemy of empathy
Act now to avoid a last-minute tax scramble
How inner-city living can transform a city by the sea
Artificial intelligence's value is the time it gives back
Why we must break the magnetic pull of London
AI scepticism is healthy - inaction isn't
What does NPPF mean for planning gain and pricing?
What new NPPF rules mean for landowners